The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $50.51

Today's change-0.33 -0.65%
Updated July 24 9:44 AM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $50.51

Today's change-0.33 -0.65%
Updated July 24 9:44 AM EDT. Delayed by at least 15 minutes.

Abbott Laboratories down (U.S.)$0.33

Abbott Laboratories is lower today, dropping (U.S.)$0.33 or 0.65% to (U.S.)$50.51. Over the last five days, shares have gained 3.59% and are currently 1.21% off of the 52-week high. Shares have outperformed the S&P 500 by 3.52% during the last year.

Key company metrics

  • Open(U.S.) $50.81
  • Previous close(U.S.) $50.84
  • High(U.S.) $50.94
  • Low(U.S.) $50.50
  • Bid / Ask(U.S.) $50.51 / (U.S.) $50.53
  • YTD % change+31.50%
  • Volume225,680
  • Average volume (10-day)5,691,790
  • Average volume (1-month)6,486,535
  • Average volume (3-month)6,452,932
  • 52-week range(U.S.) $37.38 to (U.S.) $51.13
  • Beta1.58
  • Trailing P/E77.65×
  • P/E 1 year forward20.42×
  • Forward PEG1.81×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.10%
  • Trailing EPS(U.S.) $0.65
Updated July 24 9:44 AM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue6,6376,3355,3335,302
Total other revenue--------
Total revenue6,6376,3355,3335,302
Gross profit3,4643,2913,0233,017
Total cost of revenue3,1733,0442,3102,285
Total operating expense6,2106,5374,3854,405
Selling / general / administrative2,1322,2991,6061,618
Research & development513541338352
Depreciation / amortization392522121140
Interest expense (income), net operating--------
Unusual expense (income)--1311010
Other operating expenses, total--------
Operating income427-202948897
Interest income (expense), net non-operating-183-226-153-117
Gain (loss) on sale of assets--------
Other--------
Income before tax295736875-179
Income after tax270386765-357
Income tax, total25350110178
Net income283419798-329
Total adjustments to net income--------
Net income before extra. items270386765-357
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items270386765-357
Inc. avail. to common incl. extra. items283419798-329
Diluted net income283419798-329
Dilution adjustment------0
Diluted weighted average shares1,7491,7351,4841,476
Diluted EPS excluding extraordinary itemsvalue per share0.150.220.52-0.24
Dividends per sharevalue per share0.270.270.260.26
Diluted normalized EPSvalue per share0.150.260.52-0.24